My name is Nikki and I was diagnosed with multiple sclerosis in two thousand and seven, when I was twenty seven years old. The silver lining to my diagnosis is that I was lucky enough that my GP found it when she did, because it was by complete peer accident. Had she not discovered it when she did, I probably wouldn't have shown any symptoms for about a decade later, and my condition would have been obviously worse than it was. At that time. I was just having horrible headaches, which
is not has anything to do with MS. So she sent me for an MRI and I did the test and she called me the very same day. And the fact that she called me the very same day, I was like, Oh God, what's happening. Something really bad is going on. And she's like, you know, best case scenario, you might have migraines. She goes, worst case scenario, I think you might have multiple sclerosis. So now I'm really panicking because I'm twenty seven years old. I don't know
anything about multiple sclerosis. I know it exists, you know from the media and the famous people that you here have it. Now I'm thinking I'm going to die and I'm twenty seven I haven't lived the life that everybody gets to live. I am I going to get be able to get married?
Am I?
You know what's going to happen.
So then to determine whether or.
Not I really had multiple sclerosis, I went through a battery of tests over probably the next four or five months. And if you've never had a spinal tap, let me tell you they are the world's worst creation. There's nothing positive I can say about spinal taps. I hope nobody ever has to have one. But after all that was said and done, it was pretty much one hundred percent certainty that I had multiple sclerosis, and so I kind of had to digest that and face my own mortality.
It's hard to kind of grasp the concept that your lifespan is going to be shortened. We all know we're going to die, but we it's off in the far future. We don't think about it on the day to day. We don't grasp it. It's not something we worry about. But at that point, my death seemed to be right around the corner, and it was very scary, and feelings of depression and helplessness kind of took over, and I was just not in a good place in my head just thinking about how all of this was going to
play out. But I did end up finding a fabulous multiple sclerosa specialist, and he is the best thing that I could have ever hoped or and honestly I can say without him, I would not be here talking with you today. So over the next nine years, it took that long to find a medication that I would respond to.
We tried everything. My body will either reject or not respond to lots of different medications, So with the choral medications, I just went into complete allergic reactions on every single one and it was just not going to be able to happen to stay on it. So then there's the self injectable medications, but they would burn when they would go in, and I ended up creating a lot of scar tissue around my body from where I had to inject because there's only so much skin areas you can
put them into. But when we were doing MRIs, because each drug that you go through you have to wait about six to eight months to see if they actually work, the self injectable medications did not stop any of the progression of the disease. At this point, Like I said, it had been nine years and I was just still progressing and falling down this horrible hole, and my prognosis
was really grim. At that point, we didn't really know if I was going to respond to anything or if I was just needed to prepare myself and get my affairs in order type of thing. But God loved my specialists because you did not give up on me. And there are infused medications. So I've actually been on an infused medication now for five years and it is working, which is fabulous. It really has slowed the progression of the disease. The downside of my infusions one is the cost.
My infusion is about seventh dollars a month, and had I not had insurance, there would be no way for me to receive this medication that would save my life. I would have to just die because you can't afford seven thousand dollars a month. Also, with my medication, I get very tired, like the day before and the day of I'm tired, and sort of the day after I'm tired. So it's good like forty eight hours to seventy two hours where I'm kind of just have to be still
and relax. My body just doesn't function. And the last thing that's kind of scary about my infusions is it interacts negatively with something called the JC virus, which we all have, most of us have in our brains, but nothing really happens with it because it's never really activated.
But this drug will activate it. And when it is activated and you're on this medication, your risk for PML goes right up, which is a really long medical term, but basically it's a brain infection that can cause death. So that's kind of scary. Every time I sit in the chair once a month, going is this the day? I don't know. Since it took such a long time for me to find the medication that would help me, I had gone from the beginning stages of MS to the secondary stages of MS. What that means is I
don't have flare ups anymore. My conditions and my symptoms are with me every day, all the time. Nothing changes. So my motor nerves are what's mostly affected, and so my coordination's off, my balance is off. I trip and fall a lot, and a lot of people get.
Uncomfortable when that happens, because I don't think a lot of people are.
Used to seeing someone just fall flat on their face and start laughing. So I'm definitely was a klutz before MS, but now have really shined in that area. I also have a lot of numbness and tingling in my hands and my feet they shake sometimes. Sometimes the numbness gets so bad I have to look down at the ground to actually make sure that I'm standing i can't feel it, or I have to look down at my hands to see if I'm holding something because I just can't feel
the nerve endings at the end of my fingers. It just isn't there. I get tired a lot.
I lose motivation to do things just because my body is so exhausted. Recently, I've started slurring my speech a little because my tongue just can't keep up with my brain impulses. So it sort of sounds like I'm drunk and trying to explain to people that I'm not drunk. When they think I am, they don't really listen because they're like, yeah, no, you're just wasted. I'm like, no, it's two o'clock in the afternoon. I'm just trying to
explain to you what's happening. But I would have to say the most humbling symptom that I have with my multiple sclerosis is the loss of bladder control. That is an incredibly embarrassing, sort of dejecting thing to experience because it makes you feel like you're incapable as an adult. You know, you've gone back to being a child and not being able to make it to the bathroom on time. Recently, my short term memory is evading me. I need sticky notes to get through my day. Otherwise I don't know
where I am. Sometimes I'll be in the car, I'll be driving and I have completely forgotten where I'm going. But even after all of that, I'm still one of the lucky ones who have multiple sclerosis because at this point, I don't need any assisted devices to move around. I don't need a cane yet or a walker. I do know, though, that in the future I will most likely be confined to a wheelchair. I'm not thrilled about that, obviously, but
I'm sort of resigned to it. My worry is that as my disease progresses, I'll become a burden on my loved ones that will have to take care of me because I won't be capable of doing that. And I'm scared as to how my final days will play out, because multiple sclerosis won't kill me, but the fact that I don't have an immune system will kill me. So I don't know if it'll be pneumonia or some sort of sepsis or at this point COVID. It's like a
grab bag. And so that sort of fear of the unknown really just overwhelms you at times, and you just want to sit on the couch and say, well, what's the point. But at the end of the day, you just have to do your best and get up and try to.
Keep going.
And see the lucky side, the bright side that I still can walk on my two legs and I still can have a full life where I walk my dogs or drive a car. So as much as the dark thoughts want to take over, I have to try and really stop and remind myself that it's a day by day. You can't focus.
On what could be coming.
You have to just take every day as it is and be thankful that that's where you are at that moment.
And that's my story.
Wow, it's just there's just there's just so much. Yeah, thank you so much, so much, Nikki for taking the time and being willing to share your story with us.
Yeah, thank you. We really appreciate it.
Yeah, we do. Hi.
I'm Erin Welsh and I'm Erin Alman Updike.
And this is this podcast will kill.
You Today we're talking about multiple sclerosis.
We are This is a very complicated topic. It is.
It's complicated in so many ways, and I want to say thank you again Nikki for sharing your story. I think, especially for a topic like MS, it's so important to be able to hear from people that are living with this disease, because, as I think we'll kind of see in the biology section, as much as you can learn about the specific biology of what underpins this, it just doesn't fully encompass the experience of someone who is living with this, you know.
No exactly. That's something that I came across a few times too. And the history research is that like MS, like many other diseases, are described by a series of signs and symptoms, but those signs and symptoms vary from person to person, and they don't capture the feeling of someone like how does it feel to, you know, experience this symptom or this sign, And so it just I
think that it really shows how inadequate. Are you know, diagnostic criteria are not even diagnostic criteria, but how inadequate our definitions of disease really are.
Yeah, and our and our measures of things too, because you know, we can measure like life years lost or disability scales and things like that, but that doesn't encompass like so many other parts of your life.
Yeah, no, absolutely so.
Yeah, I think that's very true for a lot of the chronic diseases that we've covered on this podcast, like sickle cell I feel like that a lot. With cystic fibrosis, I felt like that a lot. So I very much appreciate you, Nikki, Thank you so much. Yeah.
Well, is it quarantin any time?
It is?
After that, it's quarantin any time.
What are we drinking this week?
We're drinking Sylvia's Sour.
This is named for Sylvia Lowry, who I'll talk a lot more about her later, but basically, she was an incredible person who essentially like founded the National Multiple Sclerosis Society and also helped found the Multiple scleros Is International Federation. It's just like she did such an incredible amount of work to raise awareness and research funds and support funds for people living with MS, so we wanted to honor her with a quarantine drink.
So, Aaron, what is in Sylvia?
Snour It is orange and mango and rum and limejuice and some mint and yeah, I don't remember fully, but I will post the full recipe on our website this podcast will Kill You dot com, along with the non alcoholic place eber Rita recipe, and I will also post both on our social media pages Twitter, Facebook, Instagram, et cetera.
So check it out there on our website This podcast will Kill You dot com. You can find anything that you've ever wanted to find in relation to this podcast Will Kill You. You can find our merch, which we have some pretty incredible merch. You can find a bookshop dot org affiliate account. You can find transcripts of all of our episodes. You can find links to the sources that we've used in every single episode. You can find Bloodmobile, who provides our music. You can find a Patreon page.
You can find everything, anything.
Lots and lots of stuff. I actually wrote it down on a post at this time, but I left it upstairs.
Well, there you have it.
Do we have any other business or should we get into the episode, I think.
We should get into the episode right after a short break. Multiple sclerosis or MS is an autoimmune inflammatory, chronic demyelinating, neuro degenerative disease of the central nervous system.
That's a lot of adjectives.
There's a lot of words I know, and we'll get into all of them and what all of those things mean. But there are basically two major processes at play in the pathology of MS. Demyelination which occurs in an autoimmune fashion, so our own immune system attacking our nerves along with inflammation, and then scar formation or gliosis that then results in nerve damage. So those are kind of the two big picture things that are happening.
Okay.
MS has several different classifications, and will go through them all in a bit, but the relapsing remitting form of MS, which is often called RR or RMS, is the most common. I think most sources I found sent up to ninety percent of cases are the relapsing remitting form. And then there's the primary progressive form or PPMS, which is less common about ten percent, and then a secondary progressive that can result from the relapsing remitting form. So in terms
of the pathology at its core. What's happening in MS is that our neurons become demyelinated. We've talked about myelin I think before on this podcast, but I can't remember what episode, and I tried to look through my notes and I couldn't find it. But anyways, myolin is the sheath. It's the outer layer of our nerve axons. It's like an insulating layer that surrounds our nerve fibers. You can think of it as like the insulation around an electrical wire.
That's exactly how I was thinking about it.
Yeah, that's how it's most often described. Oh yeah, so without this, you know, insulating sheath, nerve impulses can't travel. Either they can't travel as quickly as they're supposed to, or they can't travel the way that they're supposed to, or sometimes they can't travel at all. They just simply can't make the jumps they need to make. So as this process of demyelination, which literally just means like the
myelin sheath is going away. As this myelin sheath becomes destroyed, nerve impulses aren't traveling from our brain to whatever target organ they're supposed to. And then this can lead to any and all different kinds of neurologic symptoms because of this lack of signal transduction. And so that's what the kind of symptoms can look. What does that actually mean in terms of disease, Let's talk about it.
Anything and everything.
Anything and everything is the real answer. So MS often starts with what is called a clinically isolated syndrome or a CIS. This is, and I think like eighty five percent of cases, the very first manifestation of MS, and it can be almost anything that's neurologic, and it just depends on where in the brain or the spinal cord this demyelination happens. So let me give you an example.
One relatively common presentation that happens in about twenty percent of people as the first sign of MS is something called optic neuritis. This is when the demylination and this inflammation happens to affect the optic nerve, which is our
second cranial nerve. Optic neuritis, when it's like this, presenting sign of MS usually happens as a pretty abrupt onset of blurry vision or loss of color vision, or complete loss of vision in one eye or sometimes the presence of like a black spot or a scotoma in the middle of your vision and pain with eye movement because of this inflammation that's happening in the nerve.
Oh okay, why is this one of the first signs?
Great question. It's just a common place that MS affects, is the optic nerve in your brain, and so it's a it's just a common place that you will then have MS presenting. And I know that's not a very satisfying answer.
Well, there's not a lot of satisfying answers in I think this episode.
Probably yep, yeah, But this optic neuritis doesn't occur exclusively in MS. It can occur in other disorders as well, but usually MS it happens just on one eye rather than both eyes, though in theory it could happen in both and in other disorders it might be more common to happen in both eyes at the same time, but that is sort of just one very small example. This type of demyelination and inflammation can happen in any part of the white matter, which is where the myelin containing
nerves are in our brain or our spinal cord. So some other common presentations of this clinically isolated syndrome or this first time presentation of what will then be MS. Could be weakness in one or more of your limbs. It could be spasticity on the flip side, which is where you know the muscles become very either flexed or they get stuck in an extended position and that can
be very painful. You can have abnormal sensation like numbness or tingling in the arms or legs, or even one that kind of comes up commonly is like a band like sensation of like a squeezing band feeling around the rib cage.
Hmm.
If the autonomic system, the autonomic system parts of your brain are what's affected, you can have bladder or bowel incontinence or loss of function. If it's the cerebellum or parts of the brain stem that are involved, then you can have difficulties walking like we've talked about on this podcast before, a taxia where you just can't coordinate your movement so you have gait difficulties. So the list of possible symptoms is very, very very.
Long, and it just depends on like where the demyelination and inflammation is happening exactly right, So I have a question about the demyelination.
What is that?
Like how fast of a process is that? And I mean, and maybe this is like way looking ahead to the future, but it is like when does myolination in general happen? And is there any possibility for like remielination.
Yeah, yes, we'll talk all about that, okay, Yes, So in general, to be classified as like a clinically isolated syndrome, these symptoms come on anywhere from over a matter of hours to a few days, so they happen kind of gradually. So this demilination is like it's a process. It's not just like and all of a sudden the myolin's gone.
Okay, it's like an unraveling, all right, Yeah, but it does happen relatively quickly, so they come on, you know, within.
Hours to a few days. To be classified as a clinically isolated syndrome, the symptoms have to last for at least twenty four hours. So we're not talking about like numbness that comes on and lasts just a few hours and then disappears. This is something that comes on lasts at least a day, but usually from days or weeks
and then does resolve. And generally, especially with a clinically isolated syndrome or a first time presentation, people do tend to recover to about eighty to one hundred percent capacity. So in the case of something like optic neuritis, you have loss of vision or drastic change in your vision, it lasts for at least twenty four hours, and then it gradually improves back to pretty close to or at your baseline level of vision. And that happens with essentially remyelination of oh of your nerves.
And then how does that happen?
Oh, Aaron will Well, we'll have to get into all of.
It, Okay, Okay, I'm sorry, You're.
Okay, it's good questions, it's just too much, okay. But so that's the symptoms, right, One of the key things because obviously all of those symptoms are incredibly broad and it's not just MS that can cause any of those symptoms, right, They're not specific in and of themselves to MS necessarily. So one of the key things to discern, especially with a first time presentation of an isolated neurologic symptom, is
whether or not there are associated MRI changes. So MRI magnetic resonance imaging is a type of imaging that's really good at looking at soft tissues and our nervous system. And there are a number of different MRI changes that you can see on different types of MRI imaging, which I'm not a radiologist, so I'm not about to get into, but there are a number of different findings on MRI
that can be relatively specific two MS. Right, So if you have these symptoms consistent with a cis a clinically isolated syndrome, and you have these typical findings on MRI, you are very likely to then go on to develop MS. Okay, and with new diagnostic criteria, if you find more than one of these MRI findings that are separate in time
and space. So either like two symptoms with two different lesions on MRI, or maybe you have lesions without symptoms, but you have lesions in different stages of healing in different places in your brain and spinal cord that together can lead to a diagnosis of MS even with a first time presentation. Does that make sense?
I think so. So Basically, like if you go to a doctor and you say, okay, I have a loss of vision in one eye and I have tingling in my hands, and then you get an MRI and they see two separate lesions associated with those two symptoms, then you get a diagnosis potentially.
Potentially Yeah, but it even could be that if you just had loss of vision and that was your only symptom, you could still have brain findings on MRI even without having clinical symptoms, right, okay, right right, And that is kind of a really big deal because for a really long time, it was the case that you could really only make the diagnosis of MS if somebody had a recurrent CIS, and that would then lead you to the diagnosis of the relapsing remitting type of MS. There are
other things that you can do. You can do lumbar punctures to look for findings that are indicative of MS. So there's a lot of different, you know, kind of things that you can put together to try and make an earlier diagnosis of MS now than we ever used to before, which is a big deal, as we'll talk about later when it comes to like starting early treatment.
Right.
So, but then, what tends to happen with MS, especially without treatment in the most common form, the relapsing remitting form, is that after this first cis this first presentation, there are recurrent relapses or attacks, and generally, especially early on in the course of disease, between the relapses, people tend to not have symptoms. But over time, as these relapses occur, and remember, each one of these could be any of
those neurologic presentations. One time it might be my hands are tingling, another time it might be I can't move my legs at all. Another time it might be I go blind in one eye. It could be any of those or any combination there. And over time, as these relapses recur, they result in progressive worsening of disability, progressive
loss of neuronal function. Because what happens is that every time this demyelination process occurs, not only do you have acute inflammation and a lot of immune reaction in that area, but then there is damage to the underlying nerves and that's difficult to repair. So our brains and spinal cord can repair the milin sheath. We have cells. That's their job is to make myelin, and they can do that, but as part of our body's natural repair process, they'res
scarring that happens in the brain. We call this gliosis, and this scarring then leads to progressive disability over time.
Right, So is that just because like the myelin sheath can't be fully repair or can't function the way it used to, or.
It's both a process of damage to the underlying nerves underneath that mielin sheath. Right, So you have direct damage to the nerves, you also have inflammation causing damage to the cells that are repairing the miolin right to the cells that are responsible for making the myolin. And then as part of our repair process, like there's different kinds of repair in our bodies. There's regeneration and then there's like repair with fibrosis and scar formation, and that's part
of our body's natural repair process. But that scarring then leads to neuronal damage.
I see.
So you can kind of think of it as sometimes the statistics say that every attack results in like eighty to one hundred percent recovery. So if you think of it as eighty percent recovery and scar formation, and then eighty percent recovery and eighty percent recovery, as these relapses accumulate, the recovery is further and further from the initial baseline.
So over time, especially without treatment, relapsing remitting MS can lead to what's called secondary progressive MS, which is where instead of seeing these discrete relapses of like new symptom onset and then recovery, you just now have like a progressive accumulation of neurologic dysfunction and disability.
Gotcha, I have a question about one of the symptoms that's often reported. Yeah, and so you know you talked about how well the symptom that you feel is related to where the demyelination and inflammation is happening, which completely makes sense, But fatigue seems to be reported, So like what is the what is the basis of fatigue? Like obviously it's a very real thing, but like where does that happen and how is that happening?
It's such a good question. I don't know. I don't think we understand at all. Fatigue. It's a huge part of MS, especially as it progresses, but it can also just be an initial presenting sign, right, Okay, And we don't know, we don't understand I think enough about fatigue. And because it's not it's not like a tinkling in
your hands, right, it's not one specific nerve. And so I think, like I said, how you can have radiologic findings on MRI that maybe don't correspond to a specific symptom, but maybe lots of little demyelination events in various areas can then result in these more generalized symptoms like a fatigue or et cetera.
Right, it's like many different signals are getting lost or being slowed down rather than one specific one.
I do know that there is some I saw paper, but I didn't have time to read through the whole paper that was trying to get at more specifically the mechanisms of MS related fatigue. So I'll put that on our website so if people are interested they can read more.
Yeah, I mean it seems like it would have huge implications for many other rates, like aic fatigue syndrome. There's like so.
Much of MS that is applicable to so many other things.
But yeah, yeah, I digress.
So the other form of MS is when this progressive worsening of neurologic function happens initially rather than the relapsing remitting happening first. And this is called primary progressive MS and happens in about ten percent of cases. Interestingly, this type of MS tends to be diagnosed in older individuals over age forty, whereas relapsing remitting tends to be diagnosed between ages twenty and forty most commonly, so they seem
to be a little different. But there's also so much overlap between these two that there's also some question whether they truly represent two different, you know, phenotypes of this disease or not. So when it comes to MS, there's a lot of questions, but there are two big, kind of separate but very related questions that full disclosure, we don't fully have answers to, and that is what is the ultimate cause of MS and what is the underlying
mechanism of damage? So the underlying mechanism of this damage is still not entirely clear. There are a number of papers that I will point listeners to with a lot of like really immunology geek heavy details on like what specific immune mediators, inflammatory markers, et cetera. Are involved. We know that especially B cells and to a lesser extent, T cells and self reactive antibodies aka autoimmunity is heavily
involved in the in the mechanistic underpinnings of MS. And we know that it's a combination of this immune response and inflammation that results in the destruction and damage to the mielin sheath and then those cells that produce it, and then that's what makes it more and more difficult to recover, et cetera.
Right, Right, because if it's an autoimmune thing where your cells are attacking your YOURSELFLF, then it's just going to be better and better at recognizing it and it's going to be more and more damage accumulates. That makes sense, Okay.
Yeah, So now to the question of what ultimately causes MS, and this is one that has been up for debate for I'm guessing you'll tell us how long.
Erin's to be one hundred and sixty years or something, right, Hey, have you not quite that?
Yeah? Yeah. The bottom line is we technically still don't know, but we know a lot. So there are a number of different genetic polymorphisms genetic changes that have been associated with an increased risk of MS. Most all of these are either near or in regions that are in some way involved in our immune response, which makes sense since
this is an immune regulated disease. And there is some good evidence that some of these regions overlap with other autoimmune diseases, which isn't that surprising.
That's very interesting.
I didn't know that. Yeah, like type one diabetes and lupus and others. There is some like mediocre evidence that some environmental risk factors like decreased sun exposure or low vitamin D levels might increase the risk of MS, like mediocre, not super strong evidence. And there's some decent evidence that smoking does increase the risk of MS.
Does that also include secondhand smoke? I assume I believe.
So that's what I have read, okay, And currently MS is also about three times more common in those assigned female at birth, although that wasn't always the case, which I think is fascinating in and of itself.
I'll talk about that great.
Can't wait. But none of these genetic or environmental factors tell the whole story. And there is another piece that for a very long time has been thought to play a big role in terms of a causal factor of MS.
This is such a big lead up, I know, I am so excited.
Can you tell?
So?
Just recently? Literally, Aaron's me this paper weeks two weeks prior to recording this episode.
We're recording this in January.
By the way, we're recording in January. This paper came out literally like two weeks ago.
I was excited about it.
I'm thrilled. Some very strong evidence has been published in support of this particular risk factor, which.
Is no no, no, no, no, no no no no.
Drum roll Epstein bar virus EBV okay for listeners. EBV or epstein bar virus. This is a human herpes virus. We've touched on a lot of different herpes viruses on this podcast. We've covered HSV one and two. We've covered virusicella, which is human herpes virus three. EBV is human herpes virus four. There's a lot of other ones. They're DNA viruses that are very highly co evolved with humans, and they have these latent analytic phases, so they're really really
good at hiding out in our immune system. Now. EBV is a virus that preferentially infects and replicates within a certain subset of our white blood cells. Are b lymphocytes. These are cells that, if we think all the way back to season two, are vaccines part one episode. If you remember that far back, barely b lymphocytes are responsible for producing antibodies. That's their number one drop. So EBV is a virus that preferentially replicates in our antibody producing cells,
and it is an incredibly ubiquitous virus. It infects ninety five percent of the human population. By the time we reach adulthood, all of us have it, and most of us will never ever even know that we were infected. Some of us might have been unlucky enough to have gotten mono infectious mononucleosis that's EBV. That's an acute EBV infect if you get it as like a teenager or young adult, but most of us get it as kids
and we never even knew that we had it. ABV has been known for a really long time to be implicated in the development of a whole bunch of different cancers Hodgkins lymphomas, B cell lymphoma's, nasopharyngial carcinoma, like the list goes on. So why am I talking about it?
About MS?
Okay, For a very long time, people thought, because of some of the findings, especially on lumbar puncture on CSF fluid, that it is very likely that there is some kind of viral component to MS, some kind of viral precursor. Because of the type of immune response that we see in the cerebral spinal fluid. So people thought for a long time there's something viral going on here, and EBV has long been thought to be one of the main
contenders to be the virs potentially associated with MS. And there have been a lot of papers throughout the years that provide evidence of kind of epidemiological support for this, and a lot of them had pretty solid links showing that infection with EBV puts you at higher risk of MS, especially symptomatic infection. So infection that results in infectious mononucleiosis or MONO is a substantially greater risk factor than just
asymptomatic EBV infection. I think people are two or three times more likely to develop MS after infectious mononucleiosis compared to asymptomatic EBV. But back to this new paper. This new paper that just came off the press lends even more support to this idea. This paper, which was published in Science on January thirteenth, twenty twenty two, showed that infection with EBV increases year risk of MS by thirty
two times. Thirty two times. Some of the early studies of lung cancer and smoking showed like a twenty five times increase in risk of lung cancer from smoking. But the other thing is that so this paper, and I just encourage everyone to read it because I'm not going into as much detail because I would talk for too long.
But they used serum samples from over ten million active duty military personnel that spanned over a decade, and they looked at eight hundred and one people who were diagnosed with MS during their time in the military and compared them to like twice as many matched controls. And from this study they were able to establish a very causal association between first EBV sero conversion that came first, then
markers of axonal degradation, degradation of the axons. They were able to find markers of that in the serum, and then later diagnosis of MS, so a causal relationship first EBV, then symptoms of neurons starting to degenerate, then a diagnosis of MS.
It's a big deal, a.
Very big deal. And they also did further studies on these serum samples that showed a disregulated antibody response that was specific to EBV, epstein bar virus and no other viruses, and they tested against a whole number of other viruses to look at like levels of antibody and dysregulation of antibody response and found a disregulated antibody response only to EBV in people who developed MS, and not for any other virus.
So why EBV? What's it doing?
Oh gosh, erin great question. We still don't know. But and even further support of this, yet another paper came out erin thank you very much for sending me this one too. This came out two days before we recorded. It found antibodies that were produced in people with MS that bind to a specific ABV viral antigen and cross react on a specific human cell surface protein that is
associated with autoimmune demyelination. And that's a lot I know, But basically this second paper that came out provided at least one possible mechanistic link that basically says, hey, this anigen that ABV has looks a lot like one of our cell anigens, right, like something on our human cells, And in people with MS, they're making antibodies that are cross reacting.
It's so interesting and it makes me wonder Like EBV has been around for a long time. It infects everyone everyone essentially, so like, what's the trigger? What? What is the sequence of events.
Right, Yes, it's so fascinating, and it's also it's why in only some people, right, right, And that's the question we truly really we don't know.
But EBV is necessarily a part of MS.
It seems, based on the most recent papers, that EBV is a necessary precursor to the development of MS. It is not sufficient EBV. Infectional loan does not cause MS, but EBV is necessary for the eventual development of MS, which is an amazing thing to be able to say it really is. Maybe someone else's like two months from now, is going to say no, no, But as of now, I mean, this is pretty amazingly strong evidence.
Yeah, I mean, and it also has a lot of implications for treatment and.
Prevention and prevention, yes, speaking of treatments, there are thankfully a lot of different treatments that are now available and that did not use to be the case. And today there is much more of a push towards early detection like I mentioned, and early initiation of what is called disease modifying therapy or DMT. And these are therapies many of them target B cells since we know that B
cells are so involved in this dysregulated immune response. Or other components of our immune system inflammatory system that are directly targeting the mechanisms of DAMA image trying to prevent this damage, prolong the time between relapses in relapsing remitting MS, and prevent the development of disability. There unfortunately aren't as
many therapies for primary progressive MS. So in both primary progressive and in relapsing remitting MS, there's also a lot of other therapies that are more towards whatever the symptoms are rather than treating the underlying disease. So there's always like a multifaceted approach to treatment. Right, that was long winded, But that's MS.
There's I mean, there's a lot there, and it's still like it's so complicated, and I have so many questions about how myelination works and what actually.
Is I I'm sorry, I'm not a neurologist and it's not my strong suit, aarin, So tell me listen. M hm, you said one hundred and sixty years. Yeah, like it's got to be around for longer than that, So like, what's up with it?
All right? I will try to get at that just after we take the short break, all right. So usually you ask me something like where did this thing come from? And obviously, like you know, we can't necessarily do that with this disease, right normally I can, right like I can at LEAs tell you what's commonly accepted to you know, for the evolutionary origins, or I can at least like take a guess or something. But multiple sclerosis I can't.
I can't do that. I don't because we don't know, like you said, what exactly causes it still, the mechanism of disease, and I can't even really make a guess because we just lack that knowledge. If it is caused in part by EBV, then you know, it seems as though EBV, like most herpes viruses, has been co evolving with humans, so it's been infecting humans since before humans
were humans. If it's caused by EBV plus genetic predisposition or EBV plus genetic predisposition plus adolescent vitamin D exposure or other environmental exposures, then we still don't know, like I said, how all of those things interact and what that means from an evolutionary perspective. I did read, though, one paper that discussed typothetically, why humans spontaneously get MS whereas other primates don't seem to, although it can be
induced experimentally, which I think is really interesting. Yeah, And in this paper it was suggested that it might have something to do with the fact that humans have big brains with a lot of myelination, so it's just like a lot of myelination and that's a costly thing, and that the peak onset of MS typically occurs around the same time that myelination kind of like ends or starts to decline or something.
Yeah, like we're not making more like your brain is still growing until you're like twenty five. Yeah, so after that point you're just losing brain.
Yeah, yep, and so and so that's seems like it coincides that transition sort of seems like it coincides with the typical age of onset for M. But I think one of the biggest challenges faced in trying to understand the potential evolutionary origins of this or any other disease whose ideology isn't well worked out, is trying to sort through which epidemiological data are actually meaningful and which are spurious or just red herrings.
Yeah.
For instance, you mentioned that over the past one hundred years there's been a shift in the ratio of who is most often diagnosed with MS.
Yes.
At the beginning of the twentieth century, the disease was diagnosed either fairly evenly in people assigned male at birth and people assigned female at birth, or it was diagnosed slightly more often in people assigned male at birth. But since the middle of the twentieth century or so, people assigned female at birth began to be more commonly diagnosed, and the ratio today, like you said, is around three one.
So is this an indication that people assigned female at birth are developing MS at higher rates today than they have historically or could it be partially an artifact from how difficult to diagnose diseases were viewed differently between men and women, especially in the days when hysteria was considered a valid diagnosis, Like this is all pre MRI, right, like before you could see a physical sign of MS as a physician.
Oh, that's such an important point, Aaron.
Yeah, So that I think is really important to consider, and it sort of is commonly talked about in the narrative of MS, like this is an increasing disease, it's increasing more in people assigned female at birth. Is that actually the case. Has there been something that changed over the past one hundred years or so, and if there has, like we shuld we'd obviously look for it. We should absolutely try to find out what that is, but we should also examine other reasons that might have led to
that shift. Okay, So that's all like a very long winded way of saying, I don't know the evolutionary origins of this disease because we don't know enough about it. Yeah, okay, fair enough, Okay, so what do we know. Let's go back to what are commonly reported as the earliest recorded cases of MS. The first is Saint Ludwina of schidem
In Holland, who was born in thirteen eighty. Around the time she was fifteen, Ludwina went out to do some ice skating and while she was skating, she lost her balance, she fell down, and she broke a rib. She never fully recovered from this, and for the rest of her life she experienced difficulty moving around, paralysis, pain, and visual deficits, all of which would come and go, but time got progressively worse until she died at the age of fifty two.
Throughout her life, Ludwina felt that she was sent to accept this suffering for the sins of others, and this was taken to be a sign of a miracle. So after she died, she was canonized and is the patron saint of ice Skaters and the chronically ill.
Wow.
Yeah, she does it all. It's still kind of debated whether or not it actually was MS the Ludwina was experiencing and how much is truth versus how much is myth or exaggerated over time or you know, certain bits are picked out to support you know, this was MS, but it does seem a lot more like MS than another early story that's commonly mentioned, which is that of Halla, a woman who was written about in the Icelandic Saga
of Saint Thorlax. So, sometime between twelve ninety three and thirteen twenty three CE, Halla suddenly lost her sight and speech. She prayed for them to recover and they did. MS could be something else, could be that, Yeah, but that was it. It was just that, just essentially. I mean, I think there was like a little bit more to it, but that was the gist.
Okay, Yeah, so you know the first.
Case of what definitely seems like MS takes place much more recently. Augustus dest was a grandson of King George the Third, who began experiencing symptoms of MS in his twenties. In a diary entry from eighteen twenty two, when he was twenty eight years old, he described being at the funeral of a close friend. Quote, I attended the funeral, there being many persons present, I struggled violently not to weep. I was, however, unable to prevent myself from so doing.
Shortly after the funeral, I was obliged to have my letters read to me and their answers written for me, as my eyes were so attacked that when fixed upon minute objects, indistinctness of vision was the consequence. Soon after, I went to Ireland, and without anything having been done to my eyes, they completely recovered their strength and distinctness of vision. For most of his life, Dest kept a journal describing his symptoms, the way he felt about them,
and his experiences with the doctors he saw. And it's a really valuable and interesting insight into this disease and how it was perceived, and it kind of shows in some ways how far we've come, but also in other ways how some things haven't really changed very much at all. So I want to read another quote from Desk from eighteen forty three, about twenty one years after that other entry.
I read quote. What I complain of now is that sitting produces a numbness all down the back part of my thighs and legs, and gives me a curious numb sensation in the lower region of the belly. When standing or walking, I cannot keep my balance without a stick. I sleep well when I am not annoyed with little nervous twitching in my legs and feet. For the first time in my life, I was attacked by giddiness in the head, vertigo, sickness, and total abruption of strength in
my limbs. I was able to drive to my own house, but totally incapable of getting out of the phaeton. I was carried up to my bedroom, where I was sick as a dog and broke out in the most profuse perspiration. And so some of these descriptions, even though they were from the early eighteen hundreds, they may sound completely familiar to people living with MS today. But hopefully what will not sound familiar are the treatments that doctors prescribed for
dest here's the selection. Leeches, beef steaks with wine twice a day, back rubs with alcohol, opium and oils being slapped, extremely hot baths, strychnine, quinine, nitric acid, ammonium carbonate, mercury, cinnamon, rhubarb, horseback riding, and a little bit of light electrotherapy. It's like getting shocked. Yeah, extremely hot baths, Like we didn't talk about this in the bio, but that's that would have exacerbated the symptoms so much it would have felt horrible.
Yeah.
So yeah, yeah, And there's a huge variety in those treatments that he was prescribed, which I think speaks to the fact that doctors clearly had no idea what was causing the disease and that no one single therapy seemed truly helpful for symptom control, let alone as a cure. And this didn't change once MS was formally described as
a disease. Throughout the first half of the eighteen hundreds, several different anatomus described lesions in the brain or along the spinal cord while doing an autopsy, which, if you remember from our pupil fever episode, had become quite popular around this time. Pathology had grown greatly as a field, and many people wanted to make a name for themselves
by identifying a new disease. One of these was Jean Martin Sharco, whose name may be familiar from our endometriosis episode, or because of a genetic disorder that bears his name Charkson Marie tooth disorder, or just because he's kind of a big figure in the early history of neurology. He played a role in the identification of many neurological disorders.
Yeah, he's a big deal.
Big deal. Charco was a French neurologist and pathologist who worked at a huge teaching hospital that was built to treat the poor women of Paris. His approach was to follow his patients for a long period of time, and, when they died, perform autopsies on their bodies to see if he could identify any pathological basis for the signs or symptoms that they reported. The story of Charcot and MS begins when he hired a woman who had some
motor problems to be his housemaid. He thought she had neurosyphilis. He kept iran until her disease progressed to the point where he was like, you can't really clean anymore, so you're going to this hospital for poor Parisian women. And he shipped her off there, oh gosh, and that's where she lived until she died, at which point he performed an autopsy and he noticed some plaques scattered throughout her
nervous system. And within a few years he had seen several more of these plaques in several more of the autopsies, and so he was thinking, hmm, okay, I think I might have a new condition here, because a lot of the people that had these plaques had reported things like numbness, vision, parlbs,
movement difficulties, speech problems, et cetera. And he noticed too that these signs and symptoms tended to relapse and roomIt and so yeah, he was like, this has got to be a new disorder, and I'm gonna go describe it. So in eighteen sixty eight, Charco gave a series of lectures that named the disease, although they didn't he didn't use the name multiple sclerosis. That would really only be settled upon in like by the nineteen fifties or so, like,
there was disseminated sclerosis. There were a ton of different names for this, but he also drew like boundaries around it.
Right.
He described the pathological anatomy, the symptomatology, pathophysiology, ideology, which he described as being anything from unknown infections, moist cold, or trauma, and treatment which he said there wasn't any He hadn't come across anything that seemed to work. And he also noted that the disease seemed to be more
common in women than in men. Does this mean that Charcot was ahead of his time, because, like I said, that's something that really only in since the mid nineteen hundreds or so people recognized and kind of yes and no. If he was ahead of his time, it wasn't for the right reasons, because let's hear why he thought people, especially women, developed ms oh yeah quote long continued grief or vexation, such for instance, as might arise from illicit
pregnancy or the disagreeable annoyances and carking cares which a more or less false social position entails. This is often the case as regards certain female teachers. Having said so much with respect to women, the question of the male sufferer arises. These are, for the most part, persons who have lost caste and who thrown out of the general current and too impressionable, are ill provided with the means of maintaining what in Darwin's theory is called the struggle for life.
Oh de end quote, Yeah, oh okay. I feel like these early descriptions have probably progressed into some of the thinking that has taken a long time to overturn, because there was a lot of like earlier studies that were like, is it stress that causes MS?
Right? And like, it couldn't possibly be that someone's disease caused them stress, right, couldn't possibly be that?
No?
And obviously, if you listen to the endometrios this episode, Charcot was involved in hysteria like he you know, was a huge influence of Freud, And there was so much much in this time that built this foundation for the disease becoming a part of someone's identity, right, or someone's identity influencing what disease they were thought to have. And it's still a big problem today and it's taken decades
to even try to undo. But anyway, for decades, Charco's description of MS from these lectures basically remained unchanged, with just a little refinement here and there not because no one was studying the disease. Charko's lectures kicked off a huge amount of interest in MS. But just because the general outline of the disease remained the same, that doesn't mean that the way it was perceived also was unchanged.
So going back to dest and his journals, I think reading through them, as well as other people's accounts of their experiences with MS in the late eighteen hundreds and early nineteen hundreds, it helps us to better consider this
disease through the lens of history. Pick any point in the history of MS from the mid eighteen hundreds and ask what else was going on in biomedical science at the time, what new discoveries have been made or technologies developed, and you'll see how that historical context affected not only the diagnosis of this disease, but also how it was
treated and what was thought to be the cause. So improvements in microscopes and the autopsy trend that led to this disease being defined because it allowed people to see the connection between these lesions and the symptoms of MS, and since germ theory was in full swing around the time MS was first fully characterized, researchers proposed microbe after microbe responsible for the disease, and even produced some MS vaccines,
none of which was able to be repeated or panned out. Really, and this focus on a microbiological cause of MS so early on it was surprising to me initially, but it also makes sense in light of the ability of syphilis to cause neurological disease. Until a lot of people were like, oh, if syphilis can do this, then you know, we see
neurological disease. This could be caused by another pathogen. Yeah, And more recently, you know, one of the current trends is the gut microbiome in general, and what are microbiota, how that influences our health and other diseases, and so there has been attention more recently regarding what role that has to play in MS. So we don't, you know,
we don't know. Maybe we'll learn more, and I think, you know, we've now with this EBV super robust study, we've kind of come full circle, and maybe some EBV vaccines in the works. Yeah. A quote from the early nineteen hundreds by Pierre Marie, a student of Charcot, may
soon seem very prophetic. Quote. I have little doubt in fact, gentlemen, that in the employment of such a substance as the vaccine of pasture or the lymph of cook, the evolution of insular sclerosis will someday be rendered absolutely impossible.
Wow, And hopefully that's true, fingers cross.
Yeah. And the prevailing medical thought at various times also affected treatment. So like with the development of salvarsan for syphilis and penicillin, people attempted to treat MS with antibiotics, And the same happened when like anticoagulant factors were developed or other types of treatments right that were effective for other diseases.
Right, any new treatment does it work for MS? Right?
And that's a completely reasonable approach. I think it also just speaks to like people where like, we don't know what is causing this. And I also think it's important to talk about how diagnosis was impacted by common bios or trends in medicine. And I've talked before about the difference between signs and symptoms and how advancements in medical technology and measuring devices led to the shift in physicians
relying more on signs than symptoms for many diseases. So like, signs are things that are observable detectable by someone who's not the person experiencing them, and symptoms are only able to be described by the person experiencing them, and so this switch from focusing more on signs rather than symptoms
that also applied for MS. In the days before MRIs, diagnosis was often described as being difficult, or maybe it was that a proper diagnosis required that a physician had to listen to and believe their patient difficult, difficult, and people with MS were often diagnosed with a variety of other conditions. In the seventeen hundreds and eighteen hundreds, that
was often paraplegia. This is what dest was diagnosed with, and paraplegia was this umbrella term under which a lot of diseases that included partial paralysis or movement disorders were thrown. And then when the spira keet that causes syphilis was identified in the late eighteen hundreds, it was common for a person living with MS to get a diagnosis of neuisiphilis, which is what another couple of people in the eighteen hundreds or early nineteen hundreds were diagnosed with formally or
just suggested to have the German poet Heinrich Heiney and WNP. Barbellian, pen name of Bruce Frederick Cummings, who wrote a book describing his life with MS titled The Journal of a Disappointed Man. So they were both thought to have neurosiphalis, but more likely MSMs, but doctors also suggested to Barbelian
that it was all in his head. And in that same vein, Margaret Gaddi, who was a Victorian novelist and naturalist who also had MS, was told by her physician that her illness was quote caused by her tendency to use excessive physical effort in gardening, using heavy tools in the manner of a man.
Oh, how dare you?
I want to see her garden. But it was incredible. But all of that sounds familiar, right, because the history of MS shares a lot of parallels with that of endometriosis and other quote invisible diseases, which is a term often used to describe diseases where doctors or other people may look at someone and go, oh, you don't look sick to me because there are no outward signs of
the disease. And I don't love this term because I think it can be misused to undermine or discredit the very real things that people with one of these diseases are experiencing. If I can't say you're sick, then you must not be sick, or those things you say you're feeling are just not real, like you're exaggerating them, right, And this is the kind of logic that led to hysteria being diagnosed for all manner of diseases, including MS.
As Maya Dusonberry puts it in her book Doing Harm quote, perhaps one of the clearest examples of an autoimmune disease carved out of the waste basket of hysteria is multiple sclerosis. That phrase is so excellent, the waste basket of hysteria, because it's like, how many things were misdiagnosed as hysteria? And this was even commented on in the early twentieth century.
Doctors were like, MS is not that difficult to diagnose, but there are a lot of misdiagnoses, with doctors most commonly confusing it with hysteria, and people living with MS were diagnosed with hysteria well into the nineteen fifties. It happened at such a high rate, in fact, that it drove the definition of hysteria to change in the early twentieth century to distinguish it from MS.
Wow I did not know that.
Yeah. But although MS remained underdiagnosed for many people, especially women, in the first half of the twentieth century, rates of diagnosis did in general go way up, and a big part of that was due to the fact that there
were simply more neurologists. By the nineteen tens the nineteen twenties or so, there had been a substantial rise in trained neurologists in the US, and not just restricted to cities but also to smaller towns and rural areas, and by the nineteen fifties, what had once been thought to be a rare disease was now considered one of the
most common illnesses of the central nervous system. And with this rise of neurologists there also grew to be more focused at ten, specifically on MS wider scale studies such as you know, the one that was able to be done with soldiers from World War One and World War Two, where we had a lot more medical information about thousands and thousands of people readily available. Which is kind of funny that this twenty twenty two paper is mirroring the same thing, but from the data from World War One
and World War Two. That's where it sort of paved the way for these large scale epidemiological studies looking at geographical trends where it seemed to be occurring at higher rates or more often diagnosed in people from more northern areas, northern regions that I want it like. I'm very excited to hear you talk more about that, because I know
it's like a more complicated story than that. But this pattern where MS seems to be more frequent in not as you go farther away from the equator, but just more northern climates and northern hemisphere has led some people to suggest that this disease has Viking roots, as in the frequent travels of Vikings in history essentially disseminated that
MS predisposition around certain places. Yeah. I don't know how much evidence there is to support this, but my guess is that as better and better genetic tools are being developed all the time, maybe we will be able to tease out some sort of historical story for why we
see what we see. By the mid nineteen fifties, there was much more awareness about multiple sclerosis among the medical community, and scientific advancements had helped to understand more about what was going on inside someone living with MS, which helped in the development of some treatments to manage the signs and symptoms of the disease. But this growth and awareness was not just limited to healthcare workers working directly on MS.
One of the biggest turning points in the history of MS happened on May first, nineteen forty five, when a woman named Sylvia Lowry, whose brother Bernard had MS, and Sylvia had gotten so frustrated by the lack of clear information and adequate treatment from her brother's physicians, and so she posted an ad in The New York Times with the following request quote multiple sclerosis, Will anyone recovered from it?
Please communicate with patient? And she got dozens of replies, like way more than she expected, and so she thought, Okay, I can't be the only person who could use this information. I'm going to bring all of these people together. And in nineteen forty seven she brought over twenty leaders in the field of neurology together to try to set objectives for an organization that was dedicated to understanding the disease
and finding a cure. Wow, and Sylvia, like I said, didn't stop at founding the Multiple Sclerosis Association, which was later changed to the National Multiple Sclerosis Society. She also helped found the Multiple Sclerosis International Federation, and for the rest of her life she campaigned incredibly hard to raise awareness of this disease and bring in more funds for research as well as supporting people living with the disease,
and her efforts were hugely successful. Her work and the work of these and other MS organizations show once again how incredibly important it is for people to share their story and how much of a positive impact patient advocacy groups can have on bringing awareness to a disease and providing support and resources to those who need it. Within ten years of the National MS Society being founded, there
were one hundred and twenty thousand members. She brought in celebrities and politicians, including Shirley Temple, which I'm now realie would have been a great quarantine. But that's okay, I would have been.
I love a Shirley Temple.
Me too, Me too? And Shirley Temple and other celebrities. They use their incredibly powerful platform for good and they turned like talk into action, right Like, instead of just being like, hey, we should you know, raise awareness for MS, it was like, no, we are raising awareness for MS, we are getting funds, we are you know, providing resources.
And this is also still a common theme today, which I think is wonderful, with celebrities like Jamie Lynn Siegler who plays Meadow on The Sopranos, which I'm finally watching right now, and former US Representative Donna Edwards and many
others raising funds and awareness for the disease. I would also just like to encourage anyone who is interested in learning more to check out the National MS Society website because it's an amazing resource for seeing the latest news, finding support, understand the signs and symptoms of the disease, and so much more.
I was also going to shot them out because I found their descriptions of symptoms and everything to be honestly so much better than most of the papers that I read.
Yeah, it was a great website. Yeah. The second half of the twentieth century saw a few more big advancements in multiple sclerosis. Outside of this huge growth and awareness, the development of clinical trials combined with better guidelines for staging the disease really helped to evaluate whether certain medications were helpful, harmful, or did nothing, something which previously had been really difficult to assess because of the relapsing, remitting
nature of this disease. And finally, the development of the MRI in the late nineteen seventies meant that you could finally visualize this disease, which helped not only with understanding more about it, but it also lent edence to the people who had had their symptoms repeatedly dismissed. Kind of reminiscent of the way that laparoscopic surgery was used to
legitimize endometriosis, just parallels. But it's true that the MRI revolutionized diagnosis, especially early diagnosis for people with MS, which, like you said, has been tremendously helpful for coming up with a treatment and management plan for people living with a disease, as well as being able to evaluate which
medications might have an impact. There is so much more that I could have included in this history in terms of like the specific medical developments and who discovered what, and who wrote this paper and who found this sign or whatever. Over the past one hundred and sixty years and that information is out there if you're interested in
learning more. I recommend the book multiple Sclerosis, The History of a Disease, but I'm going to leave off with the history here where Since them, we have many medications that seem to be very helpful in managing symptoms, and we are now so much better than we used to be in our knowledge about multiple sclerosis. But at the same time, there are still so many unanswered questions why first and foremost, because without a why, it's going to be nearly impossible to find a cure right or it's
going to be very difficult. And I also think that we still have a long way to go in terms of understanding how much of the criteria that we use to define multiple sclerosis actually captures the experience of someone living with it. So, Aaron, can you tell me more about where we stand today with MS?
I will try my best right after this break.
So.
MS is the most common demyelinating disease. It is the most common inflammatory neurodegenerative disease in young adults. It's the most common non traumatic cause of neurologic disability in young adults. It has a lot of most common designations in terms of the overall prevalence which has been increasing, and there's kind of a lot of factors that might be going
into that. In the Global Burden of Disease study, which looked at data from nineteen ninety to twenty sixteen, it was estimated that in twenty sixteen there were over two million, two hundred thousand prevalent cases of multiple sclerosis globally.
Okay, how was that distributed.
Great question, Very unevenly across the globe. So the highest prevalence by far is in North America with one hundred and sixty four cases per one hundred thousand people, closely followed by Western Europe at an estimate of one hundred and twenty seven cases per one hundred thousand people, Australasia only ninety per one hundred thousand, in Subsiharian Africa between two and three cases per one hundred thousand, Oceania two cases per one hundred thousand, So it really does vary
across the globe. You mentioned, Aaron, there is some kind of question where sometimes people say it's it's closer to the equator is less, or northern latitudes is greater. And there's even been some studies that have tried to look at even within countries, whether there are like north to south gradients in cases, and part of that is why the idea of sun exposure and vitamin D has some support as in more northern areas where you have less sun exposure is where you have higher rates of MS.
But it also doesn't hold true like one hundred percent, because there are specific indigenous populations and areas that actually have very low rates of MS, even though they live in very northern areas. So it's not the whole story, like a north to south gradient isn't the whole story, but there does seem to be at least some associations.
So what if somebody moves, like for instance, from an area of high risk to low risk or low risk to high risk, what does their risk profile look like?
Yeah, it's a good question. I read in at least one paper that, for example, migrants from low risk areas let's say Africa, to a high risk area let's say North America, those migrants still have low risk of development of MS. They came from a low risk area. When they moved to a high risk area, they still have a low risk of development of MS. But children of those migrants tend to have higher risk of development of MS, which is really interesting.
That's very interesting.
Yeah, Now, in terms of prevalence, it is interesting to look at the prevalence being increased, which it has in twenty sixteen. That prevalence rate is ten percent higher than the estimated prevalence in nineteen ninety, for example. But we are diagnosing MS earlier, which could contribute. We also have such better treatments that people are living longer with MS, so globally, the age standardized death rates decreased significantly in that time period, by about eleven percent. So those things
combined might explain some of this increase. So there's still a question as to whether an increase in prevalence means also that there is a true increase in MS, or if we're just diagnosing it better and people are living longer with it, which is always going to increase the prevalence.
Of RYS and has like the age specific rate or like incidents changed.
It's hard to get a handle on incidents, and so most all of the studies just really look at prevalence. Okay, Yeah, but it's a good question. In twenty sixteen, in this same study, it was also estimated that there were over eighteen thousand deaths due to MS in that one year alone, as well as over one million, one hundred thousand disability
adjusted life years. And we've talked about how that's not a perfect measure of the impact of a disease, but it is at least a measure that we have that this is something that is significantly impacting people's lives, right.
For a long part of their lives.
Right, exactly like diagnosis at between twenty and forty and you know, this is something that's lifelong and progressive.
Yeah.
So the good news, and I do feel like we get to end with pretty good news in terms of MS, is that there is an incredible amount of research being done. Like, yeah, two papers that came out in the last week that are a big deal. Yeah, And like we kind of really highlighted a lot in this biology section. There is
just so much that we don't know. And I think that what's especially exciting about research on MS is that the kinds of studies that are being done are incredibly important not just for MS, but also for our understanding of neurodegeneration and cell regeneration, right, and this can help in the treatment of so many different diseases and neurodegenerative disorders. This is also what has led to so many new treatments for MS and related disorders as we better understand
these kind of mechanistic underpinnings of this damage. Right, this kind of basic science is phenomenally important. And then there's also so many questions as to, you know, the genetics of why does one person develop MS after an infection with EBV and another person doesn't, Like, what is it about those immune responses? And and that is important not just for MS, but also for so many other immune disorders, right, Understanding what these triggers are, what these predispositions are, and
like what we can actually do about them. Yeah, And these new studies really showing that EBV is likely, in fact a necessary precursor to the development of MS, meaning that MS is like viral sequelae of infection with this virus. That means that we could prevent MS, right, Yeah, if we could prevent infection with EBV, And it also means we could prevent so many other things that EBV also causes, right, brickets, symphoma, mono, like so many other things, right, and moderna of COVID
vaccine fame just started. Like literally, this press release also came out within the last couple of weeks. They just started phase one trials of an mRNA vaccine targeting EBB.
Oh my gosh, it's so thrilling.
It is, And this technology has been able to happen so quickly because of the research that was done on COVID. So like, it's just it's one of these things that the interplay between the basic science research on one aspect of a disease can have implications for so many others. I just think it's really fascinating.
Yeah, so totally.
I think there are really exciting and promising things to come when it comes to MS treatment and possibly prevention.
Yeah, it really does feel like we're on the edge of having like a firm complete picture for what causes some people to develop MS, and hopefully that'll lead to better treatments or cures or tools for prevention.
Yeah.
And if it turns out that the epstein bar virus is a good way to focus those tools even better m h. And if you want to know more about EBV and all the tricky ways that it acts to cause disease or predisposed to disease. Make sure you tune in for next week's bonus episode. I am so thrilled to get to chat with doctor Mika Luftig, Associate Professor and Vice chair in the Department of Molecular Genetics and Microbiology at Duke University.
It's gonna be so good.
I am so excited. Doctor Luftig has worked on the epstein bar virus for nearly his whole career and he is going to be subjected to my many many questions on the how, the what, and the why of EBV infections. And I also want to get into some bigger picture questions about like grad school and academia, good stuff, bad stuff, all the stuff in between. I think it's I think it's going to be a good one. So make sure you mark your calendars.
Okay, tune in, don't miss it.
Sources sources, Okay, So I have several, but I'm just going to shout out one in particular, and that is a book by Jock Murray called multiple Sclerosis, The History of a Disease. And then there I have more about like evolutionary history and so on that I'll post.
I had a number of papers on the kind of general biology and a lot more on the specifics and mechanisms of the damage in MS. Specifically, I want to shout out the Science paper and the Nature paper that we're really looking at EBV and MS. Those were both
very exciting, published January twenty twenty two. And like I also said, I do want to give a special shout out to the National MS Society website because I think that it is just such a helpful breakdown of so many different aspects of MS, but especially like different symptoms of MS, because I think that's something that most of the papers just don't do a good job of explaining.
Yeah. Yeah, thanks again so much Nikki for taking the time to chat and sharing your story. It honestly means so much to.
Us, so much. Thank you. Thank you also to Bloodmobile, who provides the music for this episode and all of our episodes.
And thank you to you listeners. We hope you liked this episode. We hope that you found something new that you didn't know about and that you take a little tidbit and share it with somebody else.
Yeah yeah, tell your friends. Yeah, And a special shout out to our paper Trends. Thank you. Your support means the world to.
Us, it does okay, well, until next time, wash your hands
You filthy animals, U.
